Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Sep 5;330(9):832-842.
doi: 10.1001/jama.2023.14590.

Intensive vs Conventional Blood Pressure Lowering After Endovascular Thrombectomy in Acute Ischemic Stroke: The OPTIMAL-BP Randomized Clinical Trial

Collaborators, Affiliations
Randomized Controlled Trial

Intensive vs Conventional Blood Pressure Lowering After Endovascular Thrombectomy in Acute Ischemic Stroke: The OPTIMAL-BP Randomized Clinical Trial

Hyo Suk Nam et al. JAMA. .

Abstract

Importance: Optimal blood pressure (BP) control after successful reperfusion with endovascular thrombectomy (EVT) for patients with acute ischemic stroke is unclear.

Objective: To determine whether intensive BP management during the first 24 hours after successful reperfusion leads to better clinical outcomes than conventional BP management in patients who underwent EVT.

Design, setting, and participants: Multicenter, randomized, open-label trial with a blinded end-point evaluation, conducted across 19 stroke centers in South Korea from June 2020 to November 2022 (final follow-up, March 8, 2023). It included 306 patients with large vessel occlusion acute ischemic stroke treated with EVT and with a modified Thrombolysis in Cerebral Infarction score of 2b or greater (partial or complete reperfusion).

Interventions: Participants were randomly assigned to receive intensive BP management (systolic BP target <140 mm Hg; n = 155) or conventional management (systolic BP target 140-180 mm Hg; n = 150) for 24 hours after enrollment.

Main outcomes and measures: The primary outcome was functional independence at 3 months (modified Rankin Scale score of 0-2). The primary safety outcomes were symptomatic intracerebral hemorrhage within 36 hours and death related to the index stroke within 3 months.

Results: The trial was terminated early based on the recommendation of the data and safety monitoring board, which noted safety concerns. Among 306 randomized patients, 305 were confirmed eligible and 302 (99.0%) completed the trial (mean age, 73.0 years; 122 women [40.4%]). The intensive management group had a lower proportion achieving functional independence (39.4%) than the conventional management group (54.4%), with a significant risk difference (-15.1% [95% CI, -26.2% to -3.9%]) and adjusted odds ratio (0.56 [95% CI, 0.33-0.96]; P = .03). Rates of symptomatic intracerebral hemorrhage were 9.0% in the intensive group and 8.1% in the conventional group (risk difference, 1.0% [95% CI, -5.3% to 7.3%]; adjusted odds ratio, 1.10 [95% CI, 0.48-2.53]; P = .82). Death related to the index stroke within 3 months occurred in 7.7% of the intensive group and 5.4% of the conventional group (risk difference, 2.3% [95% CI, -3.3% to 7.9%]; adjusted odds ratio, 1.73 [95% CI, 0.61-4.92]; P = .31).

Conclusions and relevance: Among patients who achieved successful reperfusion with EVT for acute ischemic stroke with large vessel occlusion, intensive BP management for 24 hours led to a lower likelihood of functional independence at 3 months compared with conventional BP management. These results suggest that intensive BP management should be avoided after successful EVT in acute ischemic stroke.

Trial registration: ClinicalTrials.gov Identifier: NCT04205305.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Jinkwon Kim reported receipt of grants from Chong Kun Dang (2021) and serving as assistant editor for the Journal of Neurooncology and Neuroimaging (2019 to current) and on the editorial board of the Yonsei Medical Journal (2022 to current). Dr C. Lee reported receipt of grants from the National Research Foundation of Korea, funded by the Korean government (MSIT); receipt of personal fees from Novartis, Organon, Viatris, Boryung, Daiichi Sankyo, Chong Kun Dang, Daewoong, and JW Pharmaceutical; and having stock options with Mediwhale. Dr S. Park reported receipt of honoraria from Viatris, Organon, Boryung, Hanmi, Daewoong, Donga, Celltrion, Servier, Daiichi Sankyo, Chong Kun Dang, and Daewon and receipt of a research grant from Daiichi Sankyo. Dr Anderson reported receipt of funding for stroke research from the National Health and Medical Research Council of Australia, the Medical Research Council of the United Kingdom, Takeda China, and Penumbra and serving as vice president of the World Stroke Congress and editor-in-chief of Cerebrovascular Diseases. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Participant Flow
mRS indicates modified Rankin Scale; mTICI, modified Thrombolysis in Cerebral Infarction score. aFifteen patients were excluded for terminal cancer, 14 with cardiac or aortic disease, 4 with severe anemia and hematologic disease, 4 with chronic kidney disease, 4 with pneumonia, 2 with sepsis, 1 with cholecystitis, 1 with hemothorax, and 1 with radius fracture. bEleven patients were excluded for COVID-19 infection, 5 due to investigator error, 2 due to non-Korean citizenship, 2 due to immediate transfer to other hospitals, 2 due to no guardian, 2 for advanced dementia, and 6 for unknown reasons. cOne patient had prestroke disability (mRS score of 3-5) and also was transferred within 24 hours, so numbers below do not add to 11. dOne patient had prestroke disability (mRS score of 3-5) and also was transferred within 24 hours.
Figure 2.
Figure 2.. Distribution of mRS Score at 3 Months by Treatment Group
The modified Rankin Scale (mRS) score measures degree of disability (score range, 0 [symptom free] to 6 [death]). The proportion of patients who achieved functional independence at 3 months (mRS score of 0-2) was lower in the intensive management group (39.4%) than in the conventional management group (54.4%) (adjusted odds ratio, 0.56 [95% CI, 0.33-0.96]; P = .03). The mRS shift analysis also showed that the intensive management group had worse scores than the conventional management group (adjusted odds ratio, 0.65 [95% CI, 0.43-0.97]; P = .04).
Figure 3.
Figure 3.. Changes in Mean Systolic and Diastolic Blood Pressure From Randomization to 24 Hours After Randomization
Compared with conventional management, intensive management significantly lowered mean systolic blood pressure (SBP; panel A) over 24 hours (129.2 mm Hg [SD, 7.7 mm Hg] vs 138.0 mm Hg [SD, 13.6 mm Hg]; P < .001) and mean diastolic blood pressure (DBP; panel B) over 24 hours (72.0 mm Hg [SD, 8.1 mm Hg] vs 77.0 mm Hg [SD, 9.9 mm Hg]; P < .001). The mean between-group difference in SBP over 24 hours was −9.6 mm Hg (95% CI, −12.2 to −6.9 mm Hg; P < .001), while the mean between-group difference in DBP over 24 hours was −5.5 mm Hg (95% CI, −7.6 to −3.3 mm Hg; P < .001). The black line within each box is the median blood pressure value at each respective time point; the upper and lower boundaries of the boxes represent the IQRs. Data points outside the boxes either surpass 1.5 times the value of the upper quartile or are less than 1.5 times the value of the lower quartile.

Comment in

Similar articles

Cited by

References

    1. Goyal M, Menon BK, van Zwam WH, et al. ; HERMES Collaborators . Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723-1731. doi:10.1016/S0140-6736(16)00163-X - DOI - PubMed
    1. Lapergue B, Blanc R, Costalat V, et al. ; ASTER2 Trial Investigators . Effect of thrombectomy with combined contact aspiration and stent retriever vs stent retriever alone on revascularization in patients with acute ischemic stroke and large vessel occlusion: the ASTER2 randomized clinical trial. JAMA. 2021;326(12):1158-1169. doi:10.1001/jama.2021.13827 - DOI - PMC - PubMed
    1. Maier IL, Tsogkas I, Behme D, et al. . High systolic blood pressure after successful endovascular treatment affects early functional outcome in acute ischemic stroke. Cerebrovasc Dis. 2018;45(1-2):18-25. doi:10.1159/000484720 - DOI - PubMed
    1. Goyal N, Tsivgoulis G, Pandhi A, et al. . Blood pressure levels post mechanical thrombectomy and outcomes in large vessel occlusion strokes. Neurology. 2017;89(6):540-547. doi:10.1212/WNL.0000000000004184 - DOI - PubMed
    1. Martins AI, Sargento-Freitas J, Silva F, et al. . Recanalization modulates association between blood pressure and functional outcome in acute ischemic stroke. Stroke. 2016;47(6):1571-1576. doi:10.1161/STROKEAHA.115.012544 - DOI - PubMed

Publication types

Substances

Associated data